De Candia, Erica
 Distribuzione geografica
Continente #
NA - Nord America 1.907
EU - Europa 1.884
AS - Asia 607
OC - Oceania 14
SA - Sud America 12
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.437
Nazione #
US - Stati Uniti d'America 1.881
SE - Svezia 366
PL - Polonia 363
DE - Germania 340
IT - Italia 255
CN - Cina 236
SG - Singapore 145
UA - Ucraina 135
IE - Irlanda 112
FR - Francia 91
GB - Regno Unito 70
ID - Indonesia 70
IN - India 54
FI - Finlandia 42
RU - Federazione Russa 39
TR - Turchia 19
IR - Iran 18
BE - Belgio 17
CA - Canada 15
HK - Hong Kong 14
JP - Giappone 14
AU - Australia 13
HU - Ungheria 11
BR - Brasile 10
MX - Messico 10
NL - Olanda 7
VN - Vietnam 7
AT - Austria 6
CH - Svizzera 6
MY - Malesia 6
RO - Romania 6
IL - Israele 5
EG - Egitto 4
ES - Italia 4
MK - Macedonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
LT - Lituania 3
PK - Pakistan 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
JO - Giordania 2
KR - Corea 2
MN - Mongolia 2
PH - Filippine 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BZ - Belize 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 4.437
Città #
Warsaw 361
Chandler 333
Ashburn 197
Singapore 112
Dublin 107
Fairfield 106
San Mateo 90
Wilmington 83
Jakarta 70
Jacksonville 66
Woodbridge 62
Ann Arbor 59
Nanjing 54
Houston 45
Seattle 45
Boston 43
Marseille 42
Rome 41
Princeton 36
Boardman 34
Moscow 34
Dearborn 33
Beijing 32
New York 32
Milan 29
Cambridge 28
Cattolica 28
Redwood City 28
Los Angeles 25
Lawrence 20
Nanchang 18
Munich 16
Brussels 14
Hangzhou 13
Helsinki 13
Hong Kong 13
Redmond 13
Andover 12
Augusta 12
Nürnberg 12
Pune 12
Chicago 11
Izmir 11
London 11
Norwalk 11
Bremen 10
Budapest 10
Mountain View 10
San Diego 10
Zhengzhou 10
Hebei 8
Kunming 7
Shenyang 7
University Park 7
Washington 7
Bari 6
Cuauhtémoc 6
Guangzhou 6
Kish 6
Putrajaya 6
San Jose 6
Ypsilanti 6
Changsha 5
Dong Ket 5
Florence 5
Kocaeli 5
Naples 5
Ottawa 5
Sydney 5
Toronto 5
Busto Arsizio 4
Hefei 4
Jiaxing 4
Jinan 4
Leawood 4
Perugia 4
Prilep 4
Tustin 4
Abidjan 3
Acton 3
Bonn 3
Brisbane 3
Buffalo 3
Castelnuovo Rangone 3
Detroit 3
Esslingen am Neckar 3
Genzano Di Roma 3
Hadera 3
Hyderabad 3
Menlo Park 3
Monza 3
San Cesareo 3
Shanghai 3
Southend 3
São Paulo 3
Timisoara 3
Tokyo 3
Vienna 3
Zurich 3
Amersham 2
Totale 2.732
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 282
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 224
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 153
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 132
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 130
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 129
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 126
Data on the application of early coagulation support protocol in the management of major trauma patients 118
Effect of fibrinogen concentration on the velocity of platelet aggregation. 105
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 88
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 86
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 86
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 82
Functional role of protease activated receptors in vascular biology 81
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 81
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 81
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 78
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 78
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 77
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 72
Mechanisms of platelet activation by thrombin: a short history 71
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 71
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 71
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 71
Hemophilia A and von Willebrand deficiency: therapeutic implications 70
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 70
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 69
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 68
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 67
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 65
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 64
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 64
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 62
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 61
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 61
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 60
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 56
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 55
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 54
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 54
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 53
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 53
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 52
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 52
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 52
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 51
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 50
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 49
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 47
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 47
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 45
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 44
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 41
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 40
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 37
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 36
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 29
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 26
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 26
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 24
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 22
Extended coagulation profile of children with Long Covid: a prospective study 21
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 20
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 11
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 11
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 10
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 9
Totale 4.531
Categoria #
all - tutte 21.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020465 0 0 0 0 20 55 88 29 52 36 104 81
2020/2021579 29 68 12 64 70 73 46 21 50 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/2025294 24 32 113 64 61 0 0 0 0 0 0 0
Totale 4.531